BBIO · BridgeBio Pharma, Inc. · Debt
$68.15
-0.41 (-0.60%)
At close · Oct 26
Return incl. dividend (before tax)
Market Cap
$13.32B
Shares
195.49M
Volume · Oct 26
2.06M
Avg daily vol (3M)
2.47M
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Long-term debt, including current maturities | 2026-06-30 | USD 2,652,873,000 | 10-Q filed 2026-08-10 |
| Operating lease liabilities | 2026-06-30 | USD 18,288,000 | 10-Q filed 2026-08-10 |
Related accounting measures — not additional borrowingCarrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.
| |||
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Key facts
CIK
1743881
CUSIP
10806X102
13F (30d)
62 filings
58 filers
Visit website
Investor relations